Price target
223.570.00 0.00%
The 11 analysts offering 1 year price forecasts for 0A5R have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to 0A5R in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0A5R EPS for the last quarter is −0.34 SEK despite the estimation of −0.94 SEK. In the next quarter EPS is expected to reach −0.83 SEK. Track more of CALLIDITAS THERAPEUTICS AB SER'B'NPV financials and stay on top of what is up with the company.
In the next quarter CALLIDITAS THERAPEUTICS AB SER'B'NPV revenue is expected to reach 382.50 M SEK. Check out CALLIDITAS THERAPEUTICS AB SER'B'NPV revenue and earnings and make informed decisions.
According to analysts, 0A5R price target is 223.57 SEK with a max estimate of 300.12 SEK and a min estimate of 89.91 SEK. Check if this forecast comes true in a year, meanwhile watch CALLIDITAS THERAPEUTICS AB SER'B'NPV stock price chart and keep track of the current situation with 0A5R news and stock market news.
We've gathered opinions of 10 analysts rating 0A5R stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.